First in the No. 2 Business

June 13, 2014

By Medical Discovery News

Antibiotic resistance among disease-causing bacteria is a growing and dangerous problem. Bacteria resistant to one or antibiotics, like Staph and Strep, are approaching catastrophic levels. Bacteria so resistant to common antibiotics that few if any drugs are available to treat them have been dubbed superbugs. One widely feared bacterium, called Clostridium difficle or C. diff for short, causes intestinal disease so severe that it can become life-threatening. It kills almost 15,000 Americans every year, mostly the elderly. Super-resistant forms of this microbe are almost impossible to treat with antibiotics. 

This bacterium produces a powerful toxin that destroys intestinal cells and can rupture small blood vessels. It also causes abnormal intestinal behavior, mainly excess water that produces diarrhea. It’s an unpleasant and painful prospect for those infected with C. diff. 

Roughly 5-15 percent of the population carries this bacterium in their digestive system naturally, but it is kept in check by the rest of the bacterial population. But an underlying disease, antibiotics, another infection, or chemotherapy can weaken bacterial systems, allowing C. diff to expand into an infection. And a super-resistant version of C. diff can be a real problem.

As gross as it may sound, fecal transplants are getting lots of attention as an option for C. diff infections. First tried in the late 1950s, the rationale for this approach is that the disease occurs because the bacterial populations are disrupted, so providing a source of normal bacteria restores the ecology of the intestine and prevents C. diff from growing. 

Where exactly does one find fecal matter for such a transplant? It’s not as if anyone wants to ask family or friends to share their poop. Actually, there are major regulatory obstacles for fecal transplants. For instance, the fecal source must test negative for disease-causing bacteria, viruses, and parasites. Basically, it’s not something anyone can find at Whole Foods or on Amazon.

So a group of enterprising graduate students at the Massachusetts Institute of Technology (MIT) who observed a friend’s struggle with C. diff formed a company to distribute safe, certified fecal matter for transplant. OpenBiome collects, tests, and distributes fecal matter like a blood bank distributes blood. Samples are certified by Food and Drug Administration (FDA) procedures, which cost about $3,000. Then they are frozen at super-cold temperatures (-112 degrees) and shipped to hospitals and physicians. Currently, the company operates as a nonprofit and only collects a shipping and processing fee for transplant material.

We already know that our normal bacterial systems, which together make up our microbiome, help protect us from skin, urogenital, and oral diseases. Changes in our microbiome may also contribute to an underlying disease like diabetes. There is still much to be discovered about these organisms that call our bodies home, especially since we house 10 times more microbes than our own cells!

For a link to this story, click here.

Overuse of Antibiotics on Farms

By Medical Discovery News

July 21, 2012

 

 

 

Resistance to antibiotics has become a crisis that is overall alarmingly ignored. Some scientists believe without new antibiotics, medicine as practiced now will have to fundamentally change. Doctors struggle to control bacterial infections that continually evolve into lethal killers because current antibiotics are useless against them.

Bacteria have grown resistant because antibiotics have been overprescribed for the past 50 years and patients often quit taking antibiotics as soon as symptoms go away, giving bacteria an introduction to the antibiotic without killing them. Several bacteria are now considered super bugs, meaning they’re resistant to multiple antibiotics. Recent numbers show these super bacteria killed nearly 100,000 Americans in one year alone.

While doctors in the U.S. are becoming more aware and restrained in prescribing antibiotics, they account for less than 20 percent of the antibiotics used. The rest, more than 80 percent (28 million pounds), go to agriculture. But this massive amount of antibiotics is not being used to treat sick animals. Instead, subtherapeutic levels are routinely injected or added to animal water and feed to boost livestock weight and compensate for the unsanitary, packed conditions of commercial American farms.

These conditions create the perfect petri dish to produce resistant bacteria. As bacteria multiply in these tight, unsanitary conditions, the animals such as chickens, turkeys, pigs and cattle are treated with common human antibiotics that include streptomycin, kanamycin, and millions of pounds of penicillin. Studies show long-term subtherapeutic levels of antibiotics may be more conducive to producing resistant bacterial strains than the short-term, high-level antibiotic treatments of humans.

These bacteria, which thrive in the intestinal tract of animal, can contaminate human food  during slaughter, processing, and food preparation. The result is that more people die from foodborne illnesses. Looking at outbreaks caused by antibiotic-resistant bacteria over the past several decades, the Center for Science in the Public Interest concluded the responsible bacteria were resistant to 14 different antibiotics. Of those, seven are classified by the World Health Organization as critically important to human medicine and eight as highly important.

The issue has become critical enough that the EU banned the use of penicillin for animal growth, then in 2006 banned the use of all antibiotics for animal growth on farms. Though the Food and Drug Administration tried at one time to follow the EU’s move by banning penicillin use, farm lobbyists prevailed. Now the FDA is asking pharmaceutical companies to voluntarily limit the sale of antibiotics to farms to just medical treatments and only through a veterinarian (they are now available through retail stores open to the public).

This pits the FDA against the powerful agriculture industry, which defends the practice as a proven way to produce economical animal-based food products. They argue that banning antibiotics will raise food costs astronomically.

But follow-up studies in countries such as Sweden and Denmark show better handling of farm animals led to a decrease in the need for antibiotics, and retail prices on meat did not rise dramatically. Denmark cited just a one percent rise in pork prices.

Ignoring the problem is not an option as people continue to die from bacterial infections that can’t be treated by existing antibiotics, especially since many drug companies have stopped developing new, more powerful antibiotics.

For a link to this story, click here.